Skip to Main Content

Advertisement

Issue Archive

Table of Contents

BLOOD ADVANCES TALK

CLINICAL GUIDELINES

DRUG ADVANCES

REVIEW ARTICLE

CLINICAL TRIALS AND OBSERVATIONS

HEALTH SERVICES AND OUTCOMES

IMMUNOBIOLOGY AND IMMUNOTHERAPY

LYMPHOID NEOPLASIA

MYELOID NEOPLASIA

PHAGOCYTES, GRANULOCYTES, AND MYELOPOIESIS

RED CELLS, IRON, AND ERYTHROPOIESIS

THROMBOSIS AND HEMOSTASIS

TRANSFUSION MEDICINE

TRANSPLANTATION

ERRATA

  • Cover Image

    Cover Image

    issue cover

    COVER FIGURE
    Three-dimensional immunofluorescence imaging of different bone marrow vessels in a leukemic Kmt2atm2(MLLT3)Thr/KsyJ knockin mouse genetically engineered to express the MLL-AF9 fusion protein mimicking the t(9;11)(p22;q23) translocation found in patients with acute myeloid leukemia. Bone marrow sections were stained with anti-Sca1, anti-CD105, and antilaminin antibodies using a 20× objective magnification. Source: Konstantinos D. Kokkaliaris, Ninib Baryawno, and David T. Scadden. See the article by Kokkaliaris and Scadden.

Close Modal
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close Modal
Close Modal

Advertisement

X